Drugs·1 SepPlasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging OutcomesTrial in peopleInterventionsPaper
AAIC 2025 Abstract·25 DecTopline results from Phase 1/2 AAV gene therapy (LX1001) in APOE4/4 homozygotes with Alzheimer’s diseaseTrial in peopleInterventionsPaper